Business Wire | Jan 21, 2022 11:02AM EST

BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2022

Jan. 21, 2022

ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 21, 2022--BIOQUAL, Inc. (OTC-Pink:BIOQ):

Six Months Ended Three Months Ended November 30, November 30,

2021 2020 2021 2020

Revenue $ 30,674,324 $ 28,486,183 $ 15,201,565 $ 13,565,708

Income Before $ 3,557,348 $ 4,562,602 $ 1,610,943 $ 2,065,614Income Tax

Net Income $ 2,516,448 $ 3,228,002 $ 1,139,443 $ 1,461,414

Basic Earningsper Share of $ 2.81 $ 3.61 $ 1.27 $ 1.63Common Stock



Diluted Earningsper Share of $ 2.81 $ 3.61 $ 1.27 $ 1.63Common Stock



Weighted AverageNumber of SharesOutstanding For 894,416 893,694 894,416 893,976Basic EarningsPer Share



Weighted AverageNumber of SharesOutstanding For 893,423 893,694 894,428 893,976Diluted EarningsPer Share

For more detail related to the fiscal year 2022 unaudited second quarter results, please visit our web site at www.bioqual.com.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and one should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company's ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company's ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company's ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company's contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005329/en/

CONTACT: Mark G. Lewis, Ph.D., CEO (240-404-7654)